About Us

News and Events

 

Interview with the Dean: Small Molecules Show Big Promise

Dr. Szeto had dedicated her entire career to Weill Cornell, first as a medical student and then as a pharmacology researcher and professor, and was excited for what was to come next: motherhood. She and her husband had adopted a little girl, Emily, from China, and when they returned home, Dr. Szeto was sure her research would be done.


Then she had an epiphany.


Click here to read more.




W. Marcus Lambert, Ph.D, named Director of Diversity and Recruitment

Weill Cornell Graduate School of Medical Sciences (WCGS) welcomes Dr. W. Marcus Lambert as the inaugural director of diversity and recruitment, a new position created to cultivate recruitment and support the underrepresented and underserved populations of students at WCGS.

Dr. Lambert received his bachelor’s degree from Howard University and his doctorate in biomedical science at New York University (NYU) School of Medicine. His doctoral research focused on understanding the bidirectional crosstalk between glucocorticoid, the major stress hormone, and neurotrophic signaling in the brain, which may lead to a better understanding of the pathophysiology of depression and the mode of action of antidepressant drugs. After receiving his doctorate Dr. Lambert was a postdoctoral research fellow in the laboratory of Dr. Michael Garabedian at NYU School of Medicine. Additionally, Dr. Lambert studied education policy and mentoring programs in science, technology, engineering, and mathematics at the New York Academy of Sciences.

In his new role, Dr. Lambert will focus on networking with students and faculty and coordinating the ACCESS summer research program, which attracts underserved college sophomores and juniors. He plans to bring many innovative approaches to diversity and recruitment, including dynamic conferences, seminars, events, and the use of social media in networking among students, alumni and recruits.


David Christini, Ph.D., named Associate Dean for Programmatic Development at Weill Cornell Graduate School

I am pleased to announce the appointment of Dr. David Christini to the newly created role of Associate Dean for Programmatic Development of Weill Cornell Graduate School of Medical Sciences.

Dr. Christini is Professor of Medicine (Cardiology) and Professor of Physiology and Biophysics. He has served our institution in several leadership roles, most notably as the founding director of the T32-funded Tri-Institutional Training Program in Computational Biology & Medicine (CBM) and the Vice Chair for Basic Research in the Department of Medicine.


In his new role as Associate Dean for Programmatic Development, Dr. Christini will focus on academic and curricular strategy, working with the faculty and leadership of Weill Cornell and the Sloan-Kettering Institute as well as graduate student leaders. He will catalyze discussions on enhancing synergies between our graduate programs, strengthening connections between the graduate school and the medical school, evaluating how PhD training should adapt to the ever-changing biomedical science environment, building a bridge between our graduate school and Cornell NYC Tech, and many other initiatives.


Dr. Christini will continue to direct his laboratory and research program while in this new role. In addition to the Tri-I CBM T32 training grant, Dr. Christini is Principal Investigator of three NIH R01 grants. His research group is primarily focused on improving the understanding of and therapies for cardiac arrhythmias. The group investigates biophysical mechanisms of electrophysiological instabilities and arrhythmia onset, using a combination of electrophysiological and imaging experiments and cellular- to organ-level computational modeling.


Dr. Christini received his B.S. in electrical engineering from The Pennsylvania State University and his M.S. and Ph.D. in biomedical engineering at Boston University. He joined the faculty of Weill Cornell in 2000.


Please join me in congratulating Dr. Christini on his new appointment and thanking him for his leadership and dedicated service to Weill Cornell. I have no doubt that his energy and passion for graduate training will help us better achieve our goal of training the next generation of exemplary scientists who will advance medical discoveries, enrich therapies, and enhance human health.


Gary Koretzky, MD, PhD
Dean, Weill Cornell Graduate School



Apply Online by December 1st

Applications to the Weill Cornell Graduate School of Medical Sciences (WCGS) are accepted in seven programs of study for the degree of Doctor of Philosophy (PhD).

An applicant must have earned a baccalaureate degree or equivalent from a college or university of recognized standing and show promise of ability to pursue advanced study and research, as judged by his or her previous record.

Students may apply to one of the following predoctoral programs:

  • Biochemistry & Structural Biology
  • Cell & Developmental Biology
  • Immunology & Microbial Pathogenesis
  • Molecular Biology
  • Neuroscience
  • Pharmacology
  • Physiology, Biophysics & Systems Biology

Students are admitted for each academic year, which is defined by the start of courses in September. Click here for further instructions.


 

September 26, 2013

 

 

 

Dr. Sheila Nirenberg Wins MacArthur "Genius" Award

Sheila Nirenberg, Ph.D., Professor in the Physiology, Biophysics, and System Biology (PBSB) program of Weill Cornell Graduate School, was selected to receive the prestigious MacArthur "Genius" Award, which brings a $625,000, unrestricted award for her research.

 

Click here to read more.

 

 

Weill Cornell Medical College Announces New Dean of Graduate School of Medical Sciences

One of the world's leading immunologists, Dr. Gary Koretzky, has been named dean of the Weill Cornell Graduate School of Medical Sciences and senior associate dean for research at Weill Cornell Medical College, effective Oct. 1.

 

Dr. Koretzky will enhance the already-distinguished reputation of the graduate school, which offers more than a dozen doctoral and graduate programs with partnering institution the Sloan-Kettering Institute. He will also expand and oversee Weill Cornell's robust biomedical research enterprise, which is in the midst of unprecedented growth as the 480,000-square-foot Belfer Research Building nears completion.

 

Click here to read more.

 

 

 

     

Back to top